COOPER COLLINS

Profile

First Name

: COOPER

Middle Name

:

Last Name

: COLLINS

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

PERNIX THERAPEUTICS HOLDINGS, INC.

DAVID BECKER, ANTHEM BLANCHARD, TRACY CLIFFORD, STEVEN ELMS, MICHAEL PEARCE, JAMES SMITH

EXECUTIVE OFFICER, DIRECTOR

MAGNASCI FUND L.P.

LEV BLEYZER, MICHAEL BLEYZER, BRIAN DORSEY, N/A MAGNASCI GP, L.L.C., TAN PARKER

DIRECTOR

GEOM THERAPEUTICS, INC.

DOV GOLDSTEIN, YONG-ZU KIM, SEJIN PARK, DIRK THYE

DIRECTOR

ONCTERNAL THERAPEUTICS, INC.

JAMES B. BREITMEYER, M.D., PH.D., JAMES FREDDO, JAMES L. FREDDO, CAM GALLAGHER, CAM GARNER, CAM L. GARNER, SCOTT GLENN, SCOTT L. GLENN, DAVID F. HALE, DAVID JOHNSON, BRIAN LANNUTTI, WILLIAM R. LARUE, KAREN LUNDGREN, DANA MCGOWAN, LANGDON MILLER, LAUREN G. OTSUKI, CHARLES THEUER, M.D., RICHARD VINCENT

DIRECTOR

DOMINION AESTHETIC TECHNOLOGIES, INC.

JANET CAMPBELL, DENNIS CONDON, GERARD SHERIDAN

DIRECTOR

TYBR HEALTH, INC.

TOM DUGAN, TOBY HAMILTON, TIMOTHY KEANE, TIMOTHY J. KEANE, TIMOTHY J. KEANE, JR., STEPHEN RAMON, ALEX SMITH, JEFFREY TYBER

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2020-11-23

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Debt

2019-04-02

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2018-11-07

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2017-09-18

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-09-12

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-03-09

D

POOLED INVESTMENT FUND

DECLINE TO DISCLOSE

Equity

2016-08-23

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

$25,000,001 - $100,000,000

Equity

2012-12-31